Oncology Applications
-
Premium
Advanced FT-NIR Solutions for Pharmaceutical Development and Manufacturing Sector
The pharmaceutical industry includes discovering, developing, producing, and marketing drugs to be used as medications and vaccines to treat and cure patients across the globe. The modern pharmaceutical industry began in the early 1800s and continues to grow rapidly until this day. For example, in 2018, cancer drugs made nearly 100 billion U.S. dollars of revenue ...
By Galaxy Scientific Inc based in Nashua, NEW HAMPSHIRE (USA).
-
Premium
Track-Etched Polymer Membrane Filters for Diagnostics
Recovery of cervical cancer cells and isolation of circulating rare cells, detection and counting of bacteria recovered from food, beverage or cosmetics (flow cytometry, fluorescence microscopy), detection and analysis of recovered airborne particles (asbestos, AOX), ...
By it4ip S.A. based in Louvain-la-Neuve, BELGIUM.
-
Premium
Tissue Homogenizers – Sample preparation for Cancer research
Hard tissues such as those from tumors can be particularly difficult to homogenize, and animal models are often used in cancer research. Precellys homogenizer is perfectly adapted to applications of this ...
By Bertin Technologies based in Montigny-le-Bretonneux, FRANCE.
-
Patients - Getting It All – Better Cancer Resections with FIRE – Guided Surgery
The Promise: With modern diagnostic and imaging technologies, cancer can be detected earlier than ever before. And with earlier detection comes the promise of a surgical cure—that is, the complete removal (or resection) of all tumor tissue from a patient. Research has shown that patients with surgical cures have fewer complications in recovery and a greatly enhanced survival rate when compared to patients who do not achieve surgical ...
By Akrotome Imaging, Inc. based in Cleveland, OHIO (USA).
-
Microscope System for Molecular imaging of cancer
Longitudinal imaging of pancreatic cancer. Monitor in a minimally invasive manner both tissue morphology and fibrosis (fluorescein) and cathepsin activity (Prosense® 680). A very thin probe (S 650) was used to monitor the pancreas of the same mouse over 9 months. ...
By Mauna Kea Technologies based in Paris, FRANCE.
-
Drug Dolution for Gastric Cancer
Gastric cancer is a disease in which cancer cells form in the lining of the stomach. Almost all gastric cancers are adenocarcinomas, a cancer that begins in glandular tissue. Gastric cancer is often in an advanced stage when it is diagnosed. At this stage, it can often be treated, but rarely ...
By Ascelia Pharma AB based in Malmö, SWEDEN.
-
TCB001 ImmuniCell Clinical Trial
This trial investigated the safety profile of large numbers of GDT cells derived from patients and was open to certain patients with skin, kidney or lung cancers. This trial is now closed. ...
By TC BioPharm based in Holytown, UNITED KINGDOM.
-
Ceritinib
This active molecular is a selective inhibitor of ALK(anaplastic lymphoma kinase)which is a target found in NSCLC (metastatic non-small cell lung cancer).https://www.bocsci.com/ceritinib-cas-1032900-25-6-item-462148.html ...
By Alfa Chemistry based in NY, NEW YORK (USA).
-
Researchers - FIRE—Blazing a New Trail in Guided Surgery and Diagnostics
Cancer-targeted molecular probes have the potential to revolutionize surgery and diagnostics. Offering unparalleled flexibility and outstanding performance, FIRE epitomizes the cutting edge of this technology. FIRE’s quenched, substrate-based probe (qSBP) technology guides surgeons by ensuring probe signal is only seen when cancer is detected, clearly delineating tumor tissue from healthy tissue and virtually eliminating spurious background fluorescence common in other probes. ...
By Akrotome Imaging, Inc. based in Cleveland, OHIO (USA).
-
Investors - Akrotome FIRE
Advances in diagnostic methods have enabled the detection of cancer at the earliest stages when the chances for successful intervention are highest. For many solid tumors, the best chance for a cure is surgery. A surgical cure depends upon the complete removal of all cancer tissue from a patient (a “complete resection”). The main challenge of this approach is that it is very difficult for a surgeon to determine where diseased tissue ends and healthy tissue begins. The result is that many surgical ...
By Akrotome Imaging, Inc. based in Cleveland, OHIO (USA).
-
Clinicians - FIRE – A Flexible and Precise Molecular Probe Platform Expressly Designed for Cancer Surgeons
A critical factor in ensuring complete resection of a solid cancer tumor is the ability to determine where diseased tissue ends and healthy tissue begins. Our research, as well as our clinical collaborators, confirm that there is a pressing unmet clinical need: the ability to rapidly and globally assess the status of marginal tissue adjacent to a tumor while the patient is in the ...
By Akrotome Imaging, Inc. based in Cleveland, OHIO (USA).
-
Hemolung - Fully Integrated Respiratory Dialysis System (RAS) for Patients and Caregivers
Extracorporeal carbon dioxide removal (ECCO2R) provides an alternative or supplement to mechanical ventilation by removing carbon dioxide directly from the blood using techniques similar to kidney dialysis. The procedure can be performed as part of comprehensive treatment for acute respiratory failure in the intensive care ...
By ALung Technologies, Inc. based in Pittsburgh, PENNSYLVANIA (USA).
-
Drug Dolution for Liver Metastases
One of the that cancer can be a serious disease is its ability to spread to other parts of the body beyond the location of the primary tumour. When cancer cells spread to distant lymph nodes, tissues or organs, it is called metastatic ...
By Ascelia Pharma AB based in Malmö, SWEDEN.
-
PTR-MS systems for medical applications
PTR-MS are powerful tools for non-invasive, real-time breath gas analysis with many applications, such as screening for disease markers, study of pharmacokinetics or metabolic ...
By Ionicon Analytik Ges.m.b.H. based in Innsbruck, AUSTRIA.
-
Automation of molecular pathology
Tumor markers found in blood, urine and body tissues can be used in diagnosing and treating cancer. Each tumor marker is indicative of a particular disease and thus can be used for the screening, monitoring and diagnosis of specific tumor types. In addition to being used in prognosis, these molecular markers help to predict the response, resistance and toxicity to therapy. For example, BCR-ABL gene sequence detection is used to diagnose chronic myelogenous leukemia and acute lymphatic ...
By Aurora Biomed Inc. based in Vancouver, BRITISH COLUMBIA (CANADA).
-
Water treatment solutions for hospitals industry
Infections acquired in hospitals are the fourth largest killer in the US. According to statistics from the Centers for Disease Control and Prevention, every year in this country, two million hospital patients contract infections, and well over 100,000 persons die as a result thereof, more fatalities than caused by AIDS, breast cancer and car accidents together. Infections can be prevented and controlled by running rigorous, continuous programs of routine and meticulous cleaning and disinfection of equipment, ...
By Applied Oxidation LLC based in Chattanooga, TENNESSEE (USA).
-
Microbiome Therapeutics for Patients and Physicians
Seres’ microbiome therapeutics represent a transformative new approach to ...
By Seres Therapeutics, Inc. based in Cambridge, MASSACHUSETTS (USA).
-
In-Vivo Biomarkers for Breast Cancer
Breast cancer, most common cancer among ...
By Zionexa based in Fishers, INDIANA (USA).
-
Microbiotica Solutions for Clinical Data and Sample Sets
Microbiotica is using best-in-class clinical data and sample sets coupled with its unrivalled microbiome profiling capability to progress best-in-class therapeutics and biomarkers. Microbiotica has programs in IBD, Immuno-oncology and Gut Epithelial Barrier Repair developing medicines and biomarkers based on microbiota. These programs start with deep metagenomic and culture-based analysis of patient samples and involve advanced bioinformatics and machine learning, to identify highly significant bacterial ...
By Microbiotica Limited based in Little Chesterford, UNITED KINGDOM.
-
Native Bovine Hyaluronidase
Hyaluronidase degrades hyaluronan and has been found to be inappropriately regulated during cancer progression. https://www.creative-enzymes.com/product/Native-Bovine-Hyaluronidase_1233.html ...
By Creative Enzymes based in Shirley, NEW YORK (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you